




Searching News Database: tremelimumab
HSMN NewsFeed - 5 Aug 2015
Mirati Therapeutics And MedImmune Partner On Immuno-Oncology Combination In Lung Cancer
Mirati Therapeutics And MedImmune Partner On Immuno-Oncology Combination In Lung Cancer
HSMN NewsFeed - 1 Apr 2008
Pfizer Announces Discontinuation of Phase III Clinical Trial for Patients with Advanced Melanoma
Pfizer Announces Discontinuation of Phase III Clinical Trial for Patients with Advanced Melanoma